| Amount | Holding |
|---|---|
| 6.73% | Novo Nordisk A/S B |
| 5.12% | Sanofi SA |
| 4.63% | Nestle SA |
| 4.51% | SAP SE |
| 4.29% | ASML Holding NV |
| 3.82% | Roche Holding AG Dividend Right Cert. |
| 2.99% | Tesco PLC |
| 2.77% | KBC Group SA/NV |
| 2.37% | 3i Ord |
| 2.37% | Sika AG Registered Shares |
Expense Ratio Rating
1 /10
Expense Rating
0 /10
Market Score
6 /10
Category Score
5 /10
Market Size
6 /10
Columbia Contrarian Europe Fund Class C
Expenses: 2.10% (Better than 0% of similar funds)
This is a bad choice for a Europe Stock International Stocks fund. See why ยป
| Amount | Holding |
|---|---|
| 6.73% | Novo Nordisk A/S B |
| 5.12% | Sanofi SA |
| 4.63% | Nestle SA |
| 4.51% | SAP SE |
| 4.29% | ASML Holding NV |
| 3.82% | Roche Holding AG Dividend Right Cert. |
| 2.99% | Tesco PLC |
| 2.77% | KBC Group SA/NV |
| 2.37% | 3i Ord |
| 2.37% | Sika AG Registered Shares |
Minafi - The intersection of FI, minimalism & mindfulness.
Don't miss out on new posts, courses, interactive articles and more!
Join & Get Your First Course Free© 2025 Adam Fortuna
Site Map